Gyrase inhibitors and topoisomerase IV pyrimidine
2012
A compound of formula ** ** Formula wherein R is hydrogen or fluorine; X is hydrogen, -PO (OH) 2, -PO (OH) O-M +, -PO (O-) 2 * 2M + or -PO (O-) 2 D2 + *; M + is a pharmaceutically acceptable monovalent cation; and D2 + is a pharmaceutically acceptable divalent cation; or a pharmaceutically acceptable salt thereof.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI